# Equus Total Return, Inc.: overview EQS · NYSE · CIK 878932 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/eqs.md) · [Financials](/companies/eqs/financials.md) · [Filings](/companies/eqs/filings.md) · [Insiders](/companies/eqs/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.17)](/filings/0001096906-25-002103.md) | [0.29](/filings/0001096906-25-002093.md) | [(0.70)](/filings/0001096906-25-002099.md) | not reported | [0.25](/filings/0001096906-25-002095.md) | [(0.01)](/filings/0001096906-25-002093.md) | [(0.59)](/filings/0001096906-25-002090.md) | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.19](/filings/0001096906-25-002133.md) | [(0.08)](/filings/0001096906-25-002133.md) | [0.96](/filings/0001096906-26-000571.md) | [(1.38)](/filings/0001096906-26-000571.md) | [(1.03)](/filings/0001096906-26-000571.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/eqs/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $44.2k | 35,666 | | Unchanged | | [SHUFRO ROSE & CO LLC](/funds/908195.md) | 2026-06-30 | $38.8k | 31,287 | | Unchanged | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $25.2k | 20,330 | | New +20,330 | | [SCHWARZ DYGOS WHEELER INVESTMENT ADVISORS LLC](/funds/1794153.md) | 2026-06-30 | $24.8k | 20,000 | | Unchanged | | [BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC](/funds/1352860.md) | 2026-06-30 | $11.0k | 8,897 | | Reduced −205 | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $8.0k | 6,447 | | Added +1,500 | | [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $1 | 1 | | Unchanged | ## Recent filings [All 561 filings](/companies/eqs/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-13 | 21:00 ET | [8-K](/filings/0001712543-26-000051.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001712543-26-000051 | | 2026-08-14 | 21:01 ET | [10-Q](/filings/0001712543-26-000047.md) | Quarterly report, period 2026-06-30 | 0001712543-26-000047 | | 2026-07-02 | 20:00 ET | [8-K](/filings/0001712543-26-000044.md) | 5.07 Shareholder vote results | 0001712543-26-000044 | | 2026-06-23 | 12:31 ET | [SCHEDULE 13D](/filings/0001099910-26-000220.md) | Ownership report, active investor | 0001099910-26-000220 | | 2026-05-22 | 21:33 ET | [8-K](/filings/0001712543-26-000041.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001712543-26-000041 | | 2026-05-20 | 20:56 ET | [10-Q](/filings/0001712543-26-000039.md) | Quarterly report, period 2026-03-31 | 0001712543-26-000039 | | 2026-05-12 | 20:00 ET | [8-K](/filings/0001712543-26-000034.md) | 4.01 Change of auditor | 0001712543-26-000034 | | 2026-05-04 | 21:12 ET | [8-K](/filings/0001712543-26-000032.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001712543-26-000032 | | 2026-04-30 | 20:45 ET | [DEF 14A](/filings/0001712543-26-000029.md) | Proxy statement, period 2026-04-30 | 0001712543-26-000029 | | 2026-04-22 | 20:24 ET | [8-K](/filings/0001712543-26-000026.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001712543-26-000026 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001712543-26-000024.md), filed Apr 17, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 878932 - Tickers: EQS - Exchange: NYSE - SIC code: not reported - State of incorporation: DE - Filer category: Non-accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.